Editas Medicine’s Post

With greater understanding, comes greater patient outcomes. While you focus on autoimmunity diagnosis, we’ll be at your side, all the way.     Visit us at the International Congress on Autoimmunity 2024 in Ljubljana, Slovenia, 17-20 May, where you’ll trace the steps of a systemic autoimmune rheumatic disease patient journey. You’ll also uncover effective strategies for selecting the most pertinent, relevant tests, utilizing autoimmune serology results to advance toward precision medicine.     Join us at Booth #13 and discover better patient management, together.   #rheumaticdisease #autoimmunity #symposium #autoimmunity2024 #InternationalCongressOnAutoimmunity #Ljubljana2024 #polyautoimmunity #antiphospholipidsyndrome

Check out this article by Healio on the dosing of our first patient at our ClinCloud clinical trial site in our phase 2b trial of treatment for agitation in Alzheimer’s disease: https://lnkd.in/eh-aAnyU #IGCPharma #ClinicalTrials #AlzheimersDisease 

🌟 New Research Paper Alert! 🌟 The treatment of severe aortic valve stenosis has shifted significantly in favour of transcatheter procedures, even in younger and low-risk patients. This transition brings new considerations for patients with structural valve degeneration (SVD) and infective endocarditis (IE). How should we manage a patient with SVD after SAVR or TAVR? What are the options and what are the issues to consider? What about infective endocarditis (IE)? We have explored these questions in the following paper. Read it and find the right treatment for your patient: https://lnkd.in/ehihTy3k #AorticStenosis #SAVR #TAVR #SVD #InfectiveEndocarditis #MedicalResearch

This year, World Sickle Cell Day is centered around the theme: "Hope Through Progress: Advancing Sickle Cell Care, Globally." This theme underscores the global commitment to enhancing the care and treatment of sickle cell disease while fostering hope for those affected. It highlights the strides being made in medical research, treatment options, and support systems worldwide to improve the lives of individuals living with sickle cell disease. Through our diagnostic arm - Medbury Lifecheck Centre, we are dedicated to reducing the world sickle cell burden by offering comprehensive genotype testing and counseling services. Together, we can work towards a future where sickle cell disease no longer poses a threat to our loved ones. #WorldSickleCellDay #HopeThroughProgress #LifecheckCentre #GenotypeTesting #SickleCellAwareness #HealthcareInnovation #StrongerTogether #GlobalHealth #PreventSickleCell #HealthyFuture #CouplesCare #KnowYourStatus #HealthcareInnovation #StrongerTogether #GlobalHealth #PreventSickleCell #HealthyFuture #CouplesCare #KnowYourStatus

#ISBTClinical Sickle cell disease (SCD) affects millions globally, with serious complications requiring lifelong medical care, including regular blood transfusions. But did you know that transfusions in SCD patients come with unique challenges like alloimmunisation? Swipe 👉 to learn how transfusions impact SCD care and the key considerations in managing these patients. How prevalent is SCD in your region? Let’s talk about global perspectives and approaches to care in the comments! #SickleCellDisease #BloodTransfusion #ISBT #GlobalHealth #TransfusionMedicine Richard Gammon

Sickle Cell Awareness Month is a great opportunity to raise awareness about sickle cell disease, its impact, and the importance of research and support. September is Sickle Cell Awareness Month. Join us in spreading awareness about sickle cell disease, supporting those affected, and advocating for better treatment options. Together, we can make a difference. This month, we will be featuring 1. Community Support Group 2. Educational Workshop 3. Medical Support 4. Story Telling 5. SCD Clinic And many more. The above will be done this month and beyond. #sicklecellawareness #sicklecelldisease

📅Did you know that January is Glaucoma Awareness Month? Glaucoma is the second leading cause of blindness worldwide, leaving millions of patients suffering from this incurable disease. At ViaLase, we are changing the glaucoma treatment paradigm for both patient and doctor. We believe the traditional medication-first approach does not represent the optimal treatment of the disease nor the recent shift toward interventional glaucoma. Make sure you follow our page to learn how we’re changing the way glaucoma is managed. #GlaucomaAwarenessMonth #Ophthalmology #medicaltechnology  

Understanding the specifics of thyroid disorders and cancers can be overwhelming. But during National Thyroid Awareness Month, we can visit https://www.thyroid.org/ to examine these complexities, and with education, aid those in need to gain knowledge and understanding. For ECMC Primary Care services, visit https://lnkd.in/g3MPABny

Boston Keratoprosthesis (KPro) offers new hope for severe corneal disease patients who cannot undergo penetrating keratoplasty. This review explores KPro clinical trial findings and ongoing research progress. https://lnkd.in/eFKfTyj8 #Ophthalmology #ClinicalResearch #VisionScience #BostonKeratoprosthesis

Bronchopulmonary dysplasia (BPD) is a chronic lung disease affecting premature infants, characterized by impaired lung development and persistent functional issues. While the link between antenatal stress and BPD is known, the exact mechanisms remain elusive. Recent research by Dr. Elizabeth McGinn, Dr. Bradford Smith et al (2024) explores the concept of dysanapsis, the discordant growth of airways and lung tissue, as a potential contributor to late respiratory problems in infants exposed to antenatal stress. In a preclinical BPD model, endotoxin-exposed pups showed decreased FEV/FVC and impaired resistance, resembling clinical dysanapsis, suggesting that dysanapsis plays a role in abnormal lung function in this model. https://hubs.ly/Q02h2tgq0 Congratulations to the whole team at University of Colorado Denver, University of Colorado Anschutz Medical Campus, Northern Arizona University & Imperial College London. #flexiVentLungFunction #FEV #BPD #emkaSCIREQScience